Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies
- PMID: 2648493
- DOI: 10.1007/978-1-4899-1678-5_12
Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies
Abstract
Previous research demonstrated that serotonin uptake blockers (e.g., zimeldine, sertraline, fluoxetine) reduce voluntary ethanol consumption in rats and humans. However, the mechanism of action of these compounds is not well understood. It has been suggested, for example, that serotonin uptake blockade interferes with the processes that mediate the reinforcement derived from ethanol ingestion. On the other hand, there is considerable experimental evidence that suggests that the effects on alcohol intake may be an expression of a more general inhibitory role that serotonin plays in consummatory behavior. This chapter presents evidence that suggests that serotonin uptake blockers may affect ethanol intake, in part via a reduction of food intake. Current issues concerning the central versus peripheral mediation of these effects, receptor specificity, as well as alternate mechanisms of action are considered.
Similar articles
-
Serotonin uptake blockers and the treatment of alcoholism.Recent Dev Alcohol. 1989;7:267-81. doi: 10.1007/978-1-4899-1678-5_14. Recent Dev Alcohol. 1989. PMID: 2648494 Review.
-
Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers.Recent Dev Alcohol. 1989;7:255-66. doi: 10.1007/978-1-4899-1678-5_13. Recent Dev Alcohol. 1989. PMID: 2522667 Review.
-
Use of serotonin-active drugs in alcohol preference studies.Recent Dev Alcohol. 1989;7:211-23. doi: 10.1007/978-1-4899-1678-5_11. Recent Dev Alcohol. 1989. PMID: 2648492 Review.
-
Effects of serotonin uptake blockade on food, water, and ethanol consumption in rats.Alcohol Clin Exp Res. 1987 Oct;11(5):444-9. doi: 10.1111/j.1530-0277.1987.tb01920.x. Alcohol Clin Exp Res. 1987. PMID: 2960247
-
Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats.Alcohol. 1988 Sep-Oct;5(5):349-54. doi: 10.1016/0741-8329(88)90019-5. Alcohol. 1988. PMID: 3219181
Cited by
-
Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration.Psychopharmacology (Berl). 1995 Jul;120(2):134-41. doi: 10.1007/BF02246185. Psychopharmacology (Berl). 1995. PMID: 7480544
-
Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.CNS Drugs. 2004;18(15):1105-18. doi: 10.2165/00023210-200418150-00005. CNS Drugs. 2004. PMID: 15581381 Review.
-
Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity.Alcohol Clin Exp Res. 2009 Feb;33(2):332-9. doi: 10.1111/j.1530-0277.2008.00837.x. Epub 2008 Nov 19. Alcohol Clin Exp Res. 2009. PMID: 19032574 Free PMC article.
-
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Biochem Pharmacol. 2008 Jan 1;75(1):34-56. doi: 10.1016/j.bcp.2007.08.005. Epub 2007 Aug 9. Biochem Pharmacol. 2008. PMID: 17880925 Free PMC article. Review.
-
Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.Behav Pharmacol. 2008 Feb;19(1):1-12. doi: 10.1097/FBP.0b013e3282f3cf70. Behav Pharmacol. 2008. PMID: 18195589 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical